Table 2.
Control group | Single infusion | Repeated infusion | P value | ||||
---|---|---|---|---|---|---|---|
N | % | N | % | N | % | ||
Liver size | |||||||
Average | 6 | 20 | 6 | 20 | 8 | 26.7 | 1.00 |
Shrunken | 24 | 80 | 24 | 80 | 22 | 73.3 | |
Liver texture | |||||||
Cirrhotic | 30 | 100 | 30 | 100 | 30 | 100 | |
Spleen | |||||||
Average sized | 0 | 0 | 0 | 0 | 0 | 0 | 0.427 |
Mild splenomegaly | 12 | 40 | 18 | 60 | 24 | 80 | |
Moderate splenomegaly | 18 | 60 | 12 | 40 | 6 | 20 | |
Ascites | |||||||
Absent | 13 | 43.3 | 9 | 30 | 12 | 40 | 0.274 |
Mild | 5 | 16.7 | 6 | 20 | 6 | 20 | |
Moderate | 8 | 26.7 | 10 | 33.3 | 8 | 26.7 | |
Massive | 4 | 13.3 | 5 | 16.7 | 4 | 13.3 | |
Portal vein | |||||||
Patent | 30 | 100 | 30 | 100 | 30 | 100 |
None of these parameters showed significant differences among the three groups